Advertisement
Screener

CapsoVision, Inc (CV) Graph

CV Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $3.64M; Cost of revenue $1.77M; Research and development $5.31M; Operating expenses $9.45M.
  • 2026-03-31: Revenue $2.79M; Cost of revenue $1.46M; Research and development $4.43M; Operating expenses $8.42M.
  • 2025-12-31: Revenue $3.92M*; Cost of revenue $1.96M*; Research and development $5.72M*; Operating expenses $9.42M*.
  • 2025-09-30: Revenue $3.54M; Cost of revenue $1.62M; Research and development $6.09M; Operating expenses $9.93M.

Revenue flow

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CV revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Revenue$3.64MCost of revenue$1.77MGross profit$1.87MOperating expenses$9.45MOperating income-$7.58MOther income, net$17.00KResearch & development$5.31MPre-tax income-$7.48MIncome tax$0.00Net income-$7.48M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$3.64M$1.77M$5.31M$9.45M$0.00-$7.48M
2026-03-31$2.79M$1.46M$4.43M$8.42M$0.00-$7.03M
2025-12-31$3.92M*$1.96M*$5.72M*$9.42M*$24.00K*-$7.39M*
2025-09-30$3.54M$1.62M$6.09M$9.93M$0.00-$7.92M
2025-06-30$3.31M$1.50M$3.39M$6.46M$0.00-$4.63M
2025-03-31$2.78M$1.29M$3.11M$6.88M$0.00-$5.38M
2024-09-30$2.97M$1.31M$4.52M$7.46M$0.00-$5.79M
2024-06-30$2.84M$1.25M$4.22M$6.86M$0.00-$5.27M
2024-03-31(m)(m)(m)(m)(m)-$4.20M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$6.43M$3.23M$9.74M$17.87M$0.00-$14.51M
2025-06-30$6.10M$2.79M$6.50M$13.34M$0.00-$10.00M
2024-06-30$5.34M$2.35M$7.48M$12.47M$0.00-$9.46M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$9.64M$4.42M$12.59M$23.27M$0.00-$17.92M
2024-09-30$8.30M$3.66M$12.00M$19.93M$0.00-$15.26M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$13.55M$6.38M$18.31M$32.69M$24.00K-$25.32M
2024-12-31$11.76M$5.38M$15.12M$26.29M$11.00K-$19.90M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Vivani Medical, Inc. (VANI)United States$0.111B
electroCore, Inc. (ECOR)United States$0.102B
Neuraxis, INC (NRXS)United States$0.097B
Nexalin Technology, Inc. (NXL)United States$0.094B
Streamex Corp. (STEX)United States$0.089B-0.19
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B